The Intermediate Region of Helicobacter pylori vaca Is a determinant of toxin potency in a Jurkat T cell assay

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2578-2588

  González Rivera, Christian ^a   Algood, Holly M Scott ^a   Radin, Jana N ^a   McClain, Mark S ^a   Cover, Timothy L ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 INTEGRIN; INTERLEUKIN 2; TRANSCRIPTION FACTOR NFAT; VACUOLATING TOXIN;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; CELL VACUOLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE FUNCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIGENS, CD18; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-2; JURKAT CELLS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN ISOFORMS; T-LYMPHOCYTES;

EID: 84864820769     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00052-12     Document Type: Article

References (75)

1. Algood HM, Torres VJ, Unutmaz D, Cover TL. 2007. Resistance of primary murine CD4 T cells to Helicobacter pylori vacuolating cytotoxin. Infect. Immun. 75:334 -341.
2. Amieva MR, El-Omar EM. 2008. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134:306 -323.
3. Atherton JC, Blaser MJ. 2009. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest. 119:2475- 2487.
4. Atherton JC, et al. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-17777.
5. Atherton JC, Peek RM, Jr, Tham KT, Cover TL, Blaser MJ. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92-99.
6. Basso D, et al. 2008. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135:91-99.
7. Boncristiano M, et al. 2003. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 198:1887-1897.
8. Chung C, et al. 2010. Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world. J. Clin. Microbiol. 48:690-696.
9. Cover TL, Blanke SR. 2005. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 3:320 -332.
10. Cover TL, Blaser MJ. 2009. Helicobacter pylori in health and disease. Gastroenterology 136:1863-1873.
11. Cover TL, Blaser MJ. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267:10570 -10575.
12. Cover TL, Hanson PI, Heuser JE. 1997. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly. J. Cell Biol. 138:759 -769.
13. Cover TL, Krishna US, Israel DA, Peek RM, Jr. 2003. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 63:951-957.
14. Cover TL, Puryear W, Perez-Perez GI, Blaser MJ. 1991. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect. Immun. 59:1264 -1270.
15. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269:10566 -10573.
16. Dautin N, Bernstein HD. 2007. Protein secretion in Gram-negative bacteria via the autotransporter pathway. Annu. Rev. Microbiol. 61:89 -112.
17. de Bernard M, Cappon A, Del Giudice G, Rappuoli R, Montecucco C. 2004. The multiple cellular activities of the VacA cytotoxin of Helicobacter pylori. Int. J. Med. Microbiol. 293:589 -597.
18. de Bernard M, et al. 1995. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J. Biol. Chem. 270:23937-23940.
19. Domanska G, et al. 2010. Helicobacter pylori VacA toxin/subunit p34: targeting of an anion channel to the inner mitochondrial membrane. PLoS Pathog. 6:e1000878. doi:10.1371/journal.ppat.1000878.
20. Douraghi M, et al. 2009. Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development. Digestion 80:200 -207.
21. El-Bez C, Adrian M, Dubochet J, Cover TL. 2005. High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryonegative staining electron microscopy. J. Struct. Biol. 151:215-228.
22. Fischer W, Buhrdorf R, Gerland E, Haas R. 2001. Outer membrane targeting of passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter pylori. Infect. Immun. 69:6769-6775.
23. Fischer W, Prassl S, Haas R. 2009. Virulence mechanisms and persistence strategies of the human gastric pathogen Helicobacter pylori. Curr. Top. Microbiol. Immunol. 337:129 -171.
24. Foo JH, et al. 2010. Both the p33 and p55 subunits of the Helicobacter pylori VacA toxin are targeted to mammalian mitochondria. J. Mol. Biol. 401:792-798.
25. Forsyth MH, Atherton JC, Blaser MJ, Cover TL. 1998. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains. Infect. Immun. 66:3088 -3094.
26. Galmiche A, et al. 2000. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J. 19:6361- 6370.
27. Gangwer KA, et al. 2007. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain. Proc. Natl. Acad. Sci. U. S. A. 104:16293- 16298.
28. Gangwer KA, et al. 2010. Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. J. Bacteriol. 192:6126-6135.
29. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099 -1102.
30. Genisset C, et al. 2006. A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype. Infect. Immun. 74:1786 -1794.
31. Gonzalez-Rivera C, et al. 2010. Reconstitution of Helicobacter pylori VacA toxin from purified components. Biochemistry 49:5743-5752.
32. Handt LK, et al. 1995. Characterization of feline Helicobacter pylori strains and associated gastritis in a colony of domestic cats. J. Clin. Microbiol. 33:2280 -2289.
33. Hussein NR, et al. 2008. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J. Clin. Microbiol. 46:1774 -1779.
34. Ivie SE, et al. 2008. Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes. Infect. Immun. 76:2843-2851.
35. Jain P, Luo ZQ, Blanke SR. 2011. Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc. Natl. Acad. Sci. U. S. A. 108:16032-16037.
36. Ji X, et al. 2000. Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion. Infect. Immun. 68:3754 -3757.
37. Jones KR, et al. 2011. Polymorphisms in the intermediate region of VacA impact Helicobacter pylori-induced disease development. J. Clin. Microbiol. 49:101-110.
38. Jones KR, Whitmire JM, Merrell DS. 2010. A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease. Front. Microbiol. 1:115.
39. Letley DP, Rhead JL, Twells RJ, Dove B, Atherton JC. 2003. Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J. Biol. Chem. 278:26734 -26741.
40. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. 1988. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 26:93-99.
41. Loh JT, et al. 2011. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol. Biomarkers Prev. 20:2237- 2249.
42. Lupetti P, et al. 1996. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J. Cell Biol. 133:801- 807.
43. McClain MS, et al. 2001. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J. Bacteriol. 183:6499-6508.
44. McClain MS, Cover TL. 2003. Expression of Helicobacter pylori vacuolating toxin in Escherichia coli. Infect. Immun. 71:2266 -2271.
45. McClain MS, et al. 2006. Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity. Infect. Immun. 74:6188-6195.
46. McClain MS, et al. 2003. Essential role of a GXXXG motif for membrane channel formation by Helicobacter pylori vacuolating toxin. J. Biol. Chem. 278:12101-12108.
47. McClain MS, Schraw W, Ricci V, Boquet P, Cover TL. 2000. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells. Mol. Microbiol. 37:433- 442.
48. Molinari M, et al. 1998. The acid activation of Helicobacter pylori toxin VacA: structural and membrane binding studies. Biochem. Biophys. Res. Commun. 248:334 -340.
49. Nakayama M, et al. 2004. Helicobacter pylori VacA activates the p38/ activating transcription factor 2-mediated signal pathway in AZ-521 cells. J. Biol. Chem. 279:7024 -7028.
50. Nguyen VQ, Caprioli RM, Cover TL. 2001. Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin. Infect. Immun. 69:543-546.
51. Pagliaccia C, et al. 1998. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl. Acad. Sci. U. S. A. 95:10212-10217.
52. Polk DB, Peek RM, Jr. 2010. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 10:403- 414.
53. Radin JN, Gonzalez-Rivera C, Ivie SE, McClain MS, Cover TL. 2011. Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect. Immun. 79:2535-2543.
54. Rhead JL, et al. 2007. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133:926 -936.
55. Schmitt W, Haas R. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol. Microbiol. 12:307-319.
56. Schraw W, Li Y, McClain MS, van der Goot FG, Cover TL. 2002. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J. Biol. Chem. 277:34642-34650.
57. Sewald X, et al. 2008. Integrin subunit CD18 is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe 3:20 -29.
58. Sewald X, Jimenez-Soto L, Haas R. 2011. PKC-dependent endocytosis of the Helicobacter pylori vacuolating cytotoxin in primary T lymphocytes. Cell Microbiol. 13:482- 496.
59. Shaffer CL, et al. 2011. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteriahost cell interface. PLoS Pathog. 7:e1002237. doi:10.1371/ journal.ppat.1002237.
60. Sheu SM, Hung KH, Sheu BS, Yang HB, Wu JJ. 2009. Association of nonsynonymous substitutions in the intermediate region of the vacA gene of Helicobacter pylori with gastric diseases in Taiwan. J. Clin. Microbiol. 47:249 -251.
61. Skibinski DA, Genisset C, Barone S, Telford JL. 2006. The cell-specific phenotype of the polymorphic vacA midregion is independent of the appearance of the cell surface receptor protein tyrosine phosphatase beta. Infect. Immun. 74:49 -55.
62. Strobel S, et al. 1998. Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany. J. Clin. Microbiol. 36:1285-1289.
63. Suerbaum S, Michetti P. 2002. Helicobacter pylori infection. N. Engl. J. Med. 347:1175-1186.
64. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. U. S. A. 101:7727-7732.
65. Szabo I, et al. 1999. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J. 18:5517-5527.
66. Telford JL, et al. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179:1653-1658.
67. Terebiznik MR, et al. 2009. Effect of Helicobacter pylori's vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy 5:370 -379.
68. Torres VJ, Ivie SE, McClain MS, Cover TL. 2005. Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin. J. Biol. Chem. 280:21107-21114.
69. Torres VJ, VanCompernolle SE, Sundrud MS, Unutmaz D, Cover TL. 2007. Helicobacter pylori vacuolating cytotoxin inhibits activationinduced proliferation of human T and B lymphocyte subsets. J. Immunol. 179:5433-5440.
70. Van Doorn LJ, et al. 1999. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 116:823- 830.
71. Vinion-Dubiel AD, et al. 1999. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation. J. Biol. Chem. 274:37736 -37742.
72. Wang HJ, Wang WC. 2000. Expression and binding analysis of GSTVacA fusions reveals that the C-terminal approximately 100-residue segment of exotoxin is crucial for binding in HeLa cells. Biochem. Biophys. Res. Commun. 278:449-454.
73. Wang WC, Wang HJ, Kuo CH. 2001. Two distinctive cell binding patterns by vacuolating toxin fused with glutathione S-transferase: one highaffinity m1-specific binding and the other lower-affinity binding for variant m forms. Biochemistry 40:11887-11896.
74. Willhite DC, Blanke SR. 2004. Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell Microbiol. 6:143-154.
75. Ye D, Blanke SR. 2002. Functional complementation reveals the importance of intermolecular monomer interactions for Helicobacter pylori VacA vacuolating activity. Mol. Microbiol. 43:1243-1253.